FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
1-Year Return
24.36%
This Quarter Return
+9.82%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$348M
AUM Growth
+$69.6M
(+25%)
Cap. Flow
+$99.2M
Cap. Flow
% of AUM
28.51%
Top 10 Holdings %
Top 10 Hldgs %
79.53%
Holding
20
New
4
Increased
6
Reduced
7
Closed
–
Top Buys
| 1 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$74.5M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
+$11.5M |
| 3 |
Voyager Therapeutics
VYGR
|
+$9.77M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$9.11M |
| 5 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
+$6.9M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$10.8M |
| 2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$6.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$3.89M |
| 4 |
Alector
ALEC
|
+$1.14M |
| 5 |
CBAY
Cymabay Therapeutics
CBAY
|
+$430K |
Sector Composition
| 1 | Healthcare | 90.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPTX
1
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $74.5M | 21.06% |
+1,830,265
| New | +$74.5M |
|
2
Insmed
INSM
$30.8B
| $40M | 11.3% |
1,561,185
+27,302
| +2% | +$699K |
|
3
Ascendis Pharma
ASND
$12B
| $28.3M | 7.99% |
245,424
| – | – |
|
|
4
Alector
ALEC
$290M
| $21.7M | 6.14% |
1,143,462
-60,000
| -5% | -$1.14M |
|
5
Cytokinetics
CYTK
$6.38B
| $21.4M | 6.04% |
1,898,970
+175,800
| +10% | +$1.98M |
|
|
BHVN
6
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $18.8M | 5.32% |
429,690
-88,870
| -17% | -$3.89M |
|
|
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
| $18.4M | 5.2% |
2,571,258
-60,000
| -2% | -$430K |
|
8
Replimune Group
REPL
$469M
| $18M | 5.09% |
1,228,656
-1,000
| -0.1% | -$14.7K |
|
|
OPTN
9
DELISTED
OptiNose
OPTN
| $17.9M | 5.05% |
168,146
+6,319
| +4% | +$671K |
|
|
AERI
10
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $17.7M | 5.01% |
600,000
+388,177
| +183% | +$11.5M |
|
|
11
Voyager Therapeutics
VYGR
$243M
| $14.6M | 4.13% |
536,771
+358,967
| +202% | +$9.77M |
|
|
MYOK
12
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $12.9M | 3.65% |
257,452
-127,541
| -33% | -$6.4M |
|
13
Rhythm Pharmaceuticals
RYTM
$6.5B
| $10.3M | 2.92% |
469,482
+64,456
| +16% | +$1.42M |
|
|
MDCO
14
DELISTED
Medicines Co
MDCO
| $9.11M | 2.57% |
+249,672
| New | +$9.11M |
|
|
NGM
15
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $6.9M | 1.95% |
+471,269
| New | +$6.9M |
|
16
Veracyte
VCYT
$2.51B
| $5.7M | 1.61% |
+200,000
| New | +$5.7M |
|
|
IMMU
17
DELISTED
Immunomedics Inc
IMMU
| $5.35M | 1.51% |
385,751
-776,214
| -67% | -$10.8M |
|
18
SI-BONE Inc
SIBN
$704M
| $4.18M | 1.18% |
205,621
| – | – |
|
19
Arbutus Biopharma
ABUS
$939M
| $1.27M | 0.36% |
608,151
-196,295
| -24% | -$408K |
|
20
Kiniksa Pharmaceuticals
KNSA
$2.74B
| $866K | 0.24% |
63,922
| – | – |
|